NITRODERM TTS

This brand name is authorized in Austria, Cyprus, Ecuador, Germany, Hong Kong SAR China, Israel, Japan, Mexico, New Zealand, Spain, Turkey.

Active ingredients

The drug NITRODERM TTS contains one active pharmaceutical ingredient (API):

1	Glyceryl trinitrate UNII G59M7S0WS3 - NITROGLYCERIN
	Glyceryl trinitrate is a vasodilator and is used for angina of effort. Vasodilation is achieved by the releasing of free redical nitric oxide which activates guanylate cyclase and increases synthesis of guanosine 3′ and 5′-monophosphate with resultant effects on the phosphorylation of proteins in smooth muscle. If taken in excess, its vasodilatory effect can cause headache.
	Read more about Glyceryl trinitrate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NITRODERM TTS Transdermal patch	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01DA02	Glyceryl trinitrate	C Cardiovascular system → C01 Cardiac therapy → C01D Vasodilators used in cardiac diseases → C01DA Organic nitrates
Discover more medicines within C01DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	07220319, 07635813, 07635859, 07635865, 07635954
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	15.533-3-02-04, 5552-MEE-1020
ES	Centro de información online de medicamentos de la AEMPS	57358, 57359
HK	Department of Health Drug Office	17865, 21410
IL	מִשְׂרַד הַבְּרִיאוּת	568, 569
JP	医薬品医療機器総合機構	2171701S2037
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	110M83
NZ	Medicines and Medical Devices Safety Authority	3623, 3624
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504810011, 8699504810028, 8699504810035, 8699504810042